- Medical device maker Osprey Medical (OSP) has been awarded a Supplier Horizon Award by global healthcare giant Premier Inc
- The award is given in recognition of exceptional local customer service, clinical excellence, and lower costs
- Only nine Premier partners received the award this year, of which Osprey was the only cardiovascular supplier
- Premier is a global healthcare giant, connecting over 4000 hospitals and healthcare systems in the U.S. and 200,000 other providers and organisations
- Shares in Osprey are up just under four per cent this morning, currently trading for 2.8 cents each
Medical device maker Osprey Medical (OSP) has been awarded a Supplier Horizon Award by global healthcare giant Premier Inc.
Listed on the NASDAQ, Premier is focussed on improving the world of healthcare. The organisation works with an alliance of 4100 hospitals and healthcare systems in the U.S. and more than 200,000 other providers and organisations.
Premier also gives awards to partner organisations each year — awards which are held in high esteem.
Osprey told shareholders this morning it is the recipient of one such award, having been granted a Supplier Horizon Award by Premier.
Only nine suppliers received the award this year, and Osprey is the only cardiovascular supplier to get it.
Premier gives the Supplier Horizon Award in recognition of exceptional local customer service and engagement, value creation through clinical excellence and commitment to lower costs.
Osprey CEO Mike McCormick said the company is delighted to have received the award.
“Being the only cardiovascular recipient, and one of only nine winners this year; this award reinforces our innovative DyeVert technology and its ability to improve both hospital and patient outcomes,” Mike said.
Premier Senior Vice President of supply chain David A. Hargraves spoke highly of Osprey.
“Osprey supports Premier members by offering valuable products and services that help to lower supply chain costs and improve operating efficiencies,” David said .
“We’re honoured to recognize them as a Horizon Award recipient.”
Osprey is focussed on making heart imaging procedures safer for patients by reducing the amount of dye — also known as contrast — used. The company’s DyeVert tech can reduce the amount of dye necessary to image a heart by up to 40 per cent, reducing the risk of dye-related kidney damage.
Shares in the company are up 3.7 per cent following this morning’s news, currently worth 2.8 cents each at 10:47 am AEST.